We show that the absence of a Watson-Crick base pair at the end of the amino acid acceptor stem, which is a hallmark of all prokaryotic initiator tRNAs, is one of the key features that prevents them from acting as an elongator in protein synthesis. We generated mutants of Escherichia coli formylmethionine tRNA that have a base pair at the end of the acceptor stem. The mutants generated were C1-+ Ti, which had a U-A base pair, A72 --G72, which had a COG base pair, and the C1A72--T1G72 double mutant, which lacked the base pair. After aminoacylation, the activity of these and other mutant initiator methionyl-tRNAs (Met-tRNAs) in elongation were assayed in a MS2 RNA-directed E. coli protein-synthesizing system and in binding to the elongation factor Tu (EF-Tu). Unlike wild-type initiator tRNA or the T1G72 double mutant, the Ti and G72 mutant Met-tRNAs were active in elongation, the G72 mutant being more active than the Ti mutant. The Ti and G72 mutant Met-tRNAs also formed a ternary complex with elongation factor EF-Tu GTP, and their relative affinities for EF-Tu GTP paralleled their activities in elongation. Combination of the Ti or G72 mutation with mutations in the GGG-CCC sequence conserved in the anticodon stem of initiator tRNAs led to a further increase in the activities of these mutant tRNAs in elongation such that one of these mutants was now almost as good an elongator as E. coli elongator methionine tRNA.
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Of the two classes of methionine tRNAs present in all organisms, the initiator is used exclusively for initiation of protein synthesis, whereas the elongator is used for inserting methionine into internal peptidic linkages (1) (2) (3) . Prokaryotes and eukaryotic organelles such as mitochondria and chloroplasts utilize the initiator tRNAs as formylmethionyl-tRNA (fMet-tRNA), whereas the cytoplasmic protein-synthesizing systems of eukaryotes utilize it as methionyl-tRNA (MettRNA) without formylation. Consequently, in prokaryotes and in organelles the initiator Met-tRNAs are formylated to fMet-tRNA by Nl'fH4folate Met-tRNA transformylase, which is specific for the initiator species (4) . In addition to this special property, initiator tRNAs possess other properties different from those of elongator tRNAs: (i) initiator tRNAs bind to initiation factors; (ii) initiator tRNAs bind directly to the P site on the ribosome, whereas elongator tRNAs initially bind to the A site; (iii) initiator tRNAs do not bind to the ribosomal A site and, therefore, are prevented from inserting methionine into internal peptidic linkages (1) (2) (3) . In addition, the Escherichia coli fMet-tRNA is uniquely resistant to peptidyl-tRNA hydrolase (5) , an enzyme that deacylates N-acylaminoacyl-or peptidyl-linkages to all other tRNAs.
Initiator tRNAs also possess unique sequence and structural features that are absent in most elongator tRNAs (1, 6) .
Prokaryotic and eukaryotic initiator tRNAs contain a sequence of three guanines and three cytosines in the anticodon stem forming three consecutive GC pairs. Prokaryotic initiator tRNAs share two additional unique features, the absence of a Watson-Crick base pair at the end of the acceptor stem and the presence of a purine 11:pyrimidine 24 base pair instead of a pyrimidine 11:purine 24 base pair in the dihydrouridine stem (7) . The strong conservation of these unique features suggests that these features account for one or more of the unique properties of prokaryotic initiator tRNAs.
We have used oligonucleotide-directed mutagenesis (8, 9) to remove two of the above features in E. coli tRNAf2et (10) .
Previously, we showed that the GGG-CCC sequence conserved in the anticodon stem of this tRNA was important for binding of the fMet-tRNA to the P site on the ribosome (11).
In the current work, we generated several new mutant tRNAs and examined whether changes at either the end of the acceptor stem or in the conserved anticodon stem sequences allow these tRNAs to act as elongators. We show that single base mutants, T1 and G72, which contain a Watson-Crick base pair at the end of the acceptor stem, are active in elongation. These mutants bind the elongation factor Tu (EF-Tu) and their relative affinity (12) for EF-Tu-GTP parallels their activity in elongation. Changes in the GGGCCC sequence conserved in the anticodon stem do not by themselves allow the initiator to act as an elongator. Thus, of the two unique features of E. coli initiator tRNA that have been altered, one is important for initiation (11) , whereas the other is important in preventing the initiator tRNA from acting as an elongator. [35S]Methionine-labeled proteins made in vitro were recovered by alkali treatment of the incubation mixture followed by trichloroacetic acid precipitation. Protein was digested with L-1-tosylamido-2-phenylethyl chloromethyl ketonetreated trypsin (14) . The amount of radioactivity in tryptic digests was 4400 cptn for E. coli tRNAMet, 3600 cpm for the T29C30A31T39G40A41G72 mutant, and 2800 cpm for the G72 mutant, respectively. Half of each sample was used for electrophoresis (17 (12, 18) .
MATERIALS AND METHODS

RESULTS
Mutants of the tRNAfmet Gene. The mutants used in this work-T1, G72, T1G72, T2A71, T1T2A71, T2A71G72, T29-C30A31T39G40A41, TlT29C30A31T39G40A41, and T29C30-A31T39G4OA41G72-were obtained by using previously described procedures (11) . These mutants contain changes at either the acceptor stem, the anticodon stem, or both ( Fig. 1) . The mutant tRNA genes were characterized by DNA sequencing of the entire tRNA gene and mutant tRNAs were characterized by fingerprint analysis of 32P-labeled tRNAs (11 (Fig. 1) , are active in elongation. The double mutant T1G72, which lacks such a base pair, is, however, inactive in elongation. The G72 mutant is more active than the T1 mutant and is about 50% as active as elongator MetAtRNAMet. Fig. 3 shows the effect of mutations in the GGG-CCC sequence conserved in the anticodon stem of all initiator tRNAs on activity of the mutant tRNAs in elongation. Mutations in the anticodon stem alone do not allow the mutant tRNA to act as an elongator (curve 2). However, coupling of the anticodon stem mutations with either the T1 or the G72 mutant increased the activity of both of the latter mutants in elongation (compare curve 4 with curve 3 and curve 6 with curve 5). The G72 mutant with changes in the anticodon stem sequence is now about 75% as active as elongator Met-tRNAMet (compare curve 6 and curve 7).
As noted above, the T1 mutant is less active in elongation than the G72 mutant (Fig. 1) . We have found that unlike the T1 mutant, the G72 mutant Met-tRNA is a poor substrate for E. coli Met-tRNA transformylase (the ratio of Vmax/Km for wild-type tRNA over the G72 mutant being about 500) (unpublished work). Therefore, one possible explanation for the lower activity of the T1 mutant compared to the G72 mutant in elongation is that most of the T1 mutant [35S]MettRNA added to the extract is converted to ft35S]Met-tRNA, which cannot act in elongation. To rule out this possibility we combined the T1 mutation with the T2A71 mutation, which also makes the mutant Met-tRNA a very poor substrate for formylation (unpublished result; the ratio of Vm.,/Km for T1 mutant over the TiT2A71 mutant being about 150) and asked whether the activity of the TiT2A71 mutant Met-tRNA in elongation is now the same as that of the G72 mutant. Results (Fig. 4) show that although introduction of the T2A71 mutation into either the T1 or the G72 mutant increases their activities in elongation, the activity ofthe TiT2A71 mutant in elongation is still substantially lower than that of the G72 mutant. Fig. 4 
Tryptic Peptide Mapping of Proteins Synthesized in Vitro.
The predominant protein made in an MS2 RNA-directed E. coli protein-synthesizing system is the MS2 coat protein, which contains two internal AUG-encoded methionine residues (20) . Therefore, tryptic mapping of [35S]methioninelabeled proteins made in vitro can be used to ask whether mutant E. coli initiator Met-tRNAs incorporate methionine only in response to AUG or to other codons such as GUG (3, 21) . Two major peptides are present in trypsin digests of [35S]methionine-labeled proteins derived from either the G72 or the T29C30A31T39G40A41G72 mutant Met-tRNAs (Fig.  5) . The electrophoretic mobility of these peptides and the relative ratio of radioactivity in these peptides are the same (12) based on resistance of aminoacyl-tRNAs complexed with EF-Tu GTP toward ribonuclease (19) . The relative affinities shown on Table 1 were calculated on the basis of competition between each mutant Met-tRNA and either wild-type initiator Met-tRNA, elongator Met-tRNA, or other mutant MettRNAs. The wild-type initiator tRNA and the T1G72 mutant, both of which lack the base pair at the end of the acceptor stem ( Fig. 1) , do not bind to EF-Tu GTP, whereas the T1 and G72 mutants that have a base pair bind to EF-Tu-GTP. The relative affinity of T1 and G72 mutants for EF-Tu-GTP parallels their activity in elongation (Figs. 2-4) . The relative affinity of the G72 mutant Met-tRNA for EF-Tu GTP is lower by a factor of 10 than that of elongator Met-tRNAMet. However, it is comparable to that of some other E. coli aminoacyl-tRNAs such as Val-tRNA, Leu-tRNA, LystRNA, etc. (12) .
Mutations in the GGGCCC sequence conserved in the anticodon stem of initiator tRNAs have little effect on their binding to EF-Tu GTP. As expected from other work, mutant fMet-tRNAs in which the amino group of methionine is blocked by a formyl group also do not bind EF-Tu GTP (22) .
DISCUSSION
We have shown that a single base change enables the E. coli initiator tRNA to act as an elongator. The T1 and the G72 single mutations, which generate a Watson-Crick base pair at the end of the acceptor stem (Fig. 1) , enable the E. coli initiator to act as an elongator, whereas the double mutant T1G72, which does not have such a Watson-Crick base pair, is inactive in elongation (Fig. 2) . Thus, the absence of a Watson-Crick base pair at the end of the acceptor stem is one of the main features that prevents E. coli and most likely all prokaryotic initiator tRNAs from acting as elongators in protein synthesis. Schulman and Pelka (23) have shown that the same feature also accounts for the unique resistance (5) of E. coli fMet-tRNA toward peptidyl-tRNA hydrolase. Thus, the absence of a Watson-Crick base pair at the end of the acceptor stem in E. coli initiator tRNA explains at least two of its biological properties.
Of the two mutations that generate a Watson-Crick base pair at the end of the acceptor stem, the G72 mutant is much more active as an elongator than the T1 mutant. This is also reflected in the relative affinity of the Met-tRNAs derived from these two mutants for EF-TuOGTP (G72 > T1 > T1G72 wild-type tRNA). Thus, the mutant tRNAs are active in elongation primarily because they bind EF-Tu GTP, in contrast to the wild-type tRNA, which does not. In this connection it should be noted that mutant tRNAs corresponding to our T1 and G72 mutants have been obtained previously. Schulman and co-workers (22) isolated E. coli initiator tRNA carrying a C1 -) U1 change as among the products of sodium bisulfite reaction on the tRNA and showed that this tRNA bound EF-Tu GTP, although the binding was weak compared to other aminoacyl-tRNAs. Fischer et al. (24) obtained tRNA with A72 --G72 change by enzymatic manipulation of the tRNA and showed that this tRNA bound EF-Tu GTP "strongly." Neither group, however, examined the subsequent binding of these tRNAs to the ribosomal A site nor tested their function as elongators in protein synthesis.
There is no simple explanation for the observation that G72 mutant tRNA binds better to EF-Tu GTP than the T1 mutant. Since the presence of a Watson-Crick base pair at the end of the acceptor stem is considered necessary for binding of aminoacyl-tRNAs to EF-Tu'GTP, a simple possibility is that this region of the molecule "breathes" more readily in the T1 mutant, which has a U-A base pair, than in the G72 mutant, which has a C*G base pair. Studies on interaction of T1, G72, and TlG72 mutant Met-tRNAs with Met-tRNA transformylase (unpublished work) suggest that there are differences in structure of the acceptor stem between the T1 and G72 mutants. This does not, however, explain the observation that Gln-tRNA, which has a U-A base pair at the end of the acceptor stem, is among aminoacyl-tRNAs with the highest affinity for EF-Tu GTP (12) .
Our results that the T1, G72, TiT2A71, and T2A71G72 mutants, which retain the GGG CCC sequence in the anticodon stem conserved in initiator tRNAs, bind to ribosomal A site and are active in elongation do not necessarily conflict with the prevailing notion that the role of the GGGOCCC sequence is to endow the anticodon loop of initiator tRNA a unique conformation, which is important for targeting the initiator tRNA to the ribosomal P site during initiation (25) . It is possible that though the anticodon loop conformation of initiator tRNAs is "tailored" to fit into the ribosomal P site, it could also fit into the ribosomal A site, although perhaps less well than elongator tRNAs do. Our results agree with those of Yarus and coworkers (26) , who introduced the GGG-CCC sequence in the anticodon stem of Su7 amber suppressor tRNA and showed that the mutant tRNA was still an efficient amber suppressor in E. coli. Although the mutant with changes in the GGG0CCC sequence of E. coli initiator tRNA is in itself not active in elongation (Fig. 3) , introduction of this mutation into either the T1 or the G72 mutant increases the activity of both mutants in elongation. This occurs without any significant increase in the affinity of the respective mutants for EFTu GTP (Table 1) . There are two possible explanations for this result. One is that the mutation in the GGG0CCC sequence in the anticodon stem changes the conformation of the anticodon loop into that of a typical elongator tRNA such that the tRNA now fits better into the ribosomal A site. We showed previously that a conformational change of the anticodon loop does indeed occur with this mutant (11) . The other possible explanation is that the changes that we have introduced in the anticodon stem sequence provide more favorable contacts between the anticodon stem and protein and/or RNA components of the ribosomal A site. The latter explanation corresponds to the "extended anticodon hypothesis" of Raftery and Yarus (27) . The limited number of mutants in the anticodon stem that we have studied do not allow a choice among these possibilities. Introduction of an additional T2A71 mutation into either a T1 or a G72 mutant also increases the activity of the latter mutants in elongation. It is not known whether this is due to a slightly higher affinity for EF-TuOGTP of the TiT2A71 and T2A71G72 mutants over T1 and G72 mutants, respectively (data not shown), or whether introduction of the T2A71 mutation provides more favorable contacts for the mutant initiator tRNAs near the CCA end and amino acid-binding region of the ribosomal A site.
Finally, although the T1 and the G72 single-base mutants are active in elongation in vitro, we do not know whether either of these mutants will act as elongators in vivo. However, of these two mutants, the G72 mutant is more likely to do so for the following reasons. First, affinity of the T1 mutant for EF-Tu GTP is substantially lower than that of the G72 mutant (Table 1) . Second, although the T1 mutant Met-tRNA is an excellent substrate for E. coli Met-tRNA transformylase (ref. 28; unpublished observations), the G72 mutant is a poor substrate for this enzyme. This would mean that in vivo most of the T1 mutant will be present not as Met-tRNA but as fflet-tRNA, which (i) does not bind EF-Tu GTP and (ii) cannot participate in elongation. Because of its low affinity for EF-Tu-GTP, the small amounts of T1 mutant Met-tRNA present in vivo are unlikely to act as an elongator, to any significant extent. In contrast, most of the G72 mutant will be present as Met-tRNA and, since it has a fairly high affinity for EF-Tu GTP, will most likely act as an elongator in vivo. Additionally, since formylation of the initiator Met-tRNA is important for initiation, the G72 mutant is less likely to act as an initiator in vivo to any significant extent. Thus, the G72 mutation may, in effect, be considered a mutation that has switched the function of a tRNA from initiation to elongation.
